|
||||||||||||||||||||||||||||||||||
[發(fā)表評論] [本類其他產(chǎn)品] [本類其他供應商] [收藏] |
銷售商: 上海皓元生物醫(yī)藥科技有限公司 | 查看該公司所有產(chǎn)品 >> |
MCE 的所有產(chǎn)品僅用作科學研究或藥證申報,我們不為任何個人用途提供產(chǎn)品和服務。
CAS No. : 251456-60-7
MCE 國際站:M344
產(chǎn)品活性:M344 (D 237) 是一種組蛋白去乙;敢种苿IC50 為 100 nM。
研究領(lǐng)域:Cell Cycle/DNA Damage | Epigenetics
作用靶點:HDAC
In Vitro: M344 is a potential histone deacetylase (HDAC) inhibitor. With increasing concentrations of M344, there is a dose dependant decrease in BRCA1 mRNA and treatment with both 1 and 5 μM concentrations of M344 resulting in a significant decrease in BRCA1 expression in all cell lines examined. M344 in combination with Cisplatin leads to a decrease in BRCA1 mRNA expression as compared to Cisplatin treatment alone in all cell lines with the exception of A2780s, which is recognized as having potent cytotoxicity to Cisplatin. In the MCF7 cell line, BRCA1 is down regulated at physiological doses of M344 (0.5 μM and 1 μM) but M344 does not have the same inhibitory effect on BRCA1 at the 5.0 μM dose. Co-treatment with Cisplatin and increasing concentrations of M344 reduces BRCA1 protein levels in all breast and ovarian cell lines examined.
相關(guān)產(chǎn)品:Bioactive Compound Library Plus | Cell Cycle/DNA Damage Compound Library | Epigenetics Compound Library | Histone Modification Research Compound Library | Anti-Cancer Compound Library | Anti-Aging Compound Library | Reprogramming Compound Library | Oxygen Sensing Compound Library | Anti-Breast Cancer Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Blood Cancer Compound Library | Anti-Liver Cancer Compound Library | Osteogenesis Compound Library | Anti-Hematopathy Compound Library | Trichostatin A | Vorinostat | 4-Phenylbutyric acid | Valproic acid | Sulforaphane | Panobinostat | Entinostat | Romidepsin | Tucidinostat | RGFP966 | Belinostat | Ricolinostat | Tubastatin A | TMP195 | Theophylline | Carbamazepine | Santacruzamate A | Mocetinostat | ITSA-1 | Tasquinimod | TMP269 | Tubacin | LMK-235 | Fimepinostat | Quisinostat | PCI-34051 | FT895
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種全球獨家化合物庫,我們致力于為全球科研客戶提供前沿最全的高品質(zhì)小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領(lǐng)域;
• 產(chǎn)品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產(chǎn)品,廣泛應用于新藥研發(fā)、生命科學等科研項目;
• 提供虛擬篩選,離子通道篩選,代謝組學分析檢測分析,藥物篩選等專業(yè)技術(shù)服務;
• 設有專業(yè)的實驗中心和嚴格的質(zhì)控、驗證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質(zhì)檢報告,確保產(chǎn)品的高純度、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥專利收錄了MCE客戶的科研成果;
• 專業(yè)團隊跟蹤最新的制藥及生命科學研究進展,為您提供全球最新的活性化合物;
• 與世界各大制藥公司及知名科研機構(gòu)建立了長期的合作。